Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' OrganisationP H B Bolton-Maggs, D J Perry, E A Chalmers, et al.
Journal of Natural Products|May 1, 1995
Antineoplastic agents, 326. The stereochemistry of bastadins 8, 10, and 12 from the Bismarck archipelago marine sponge Ianthella bastaG R Pettit, M S Butler, C G Bass, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 23, 1998
Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive ratsM Thierry-Palmer, K S Carlyle, M D Williams, et al.
Infection|May 1, 2009
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registryR Beale, K Reinhart, F M Brunkhorst, et al.
Anti-Cancer Drug Design|June 17, 1998
Antineoplastic agents 365. Dolastatin 10 SAR probesG R Pettit, J K Srirangam, J Barkoczy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinomaE Massarelli, H Lin, L E Ginsberg, et al.
Pediatric Hematology and Oncology|February 5, 1999
Pediatric oncology and hematology in Birmingham, EnglandJ R Mann, P J Darbyshire, A Goodman, et al.
British Journal of Haematology|September 12, 2023
Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myelomaConnor M D Williams, Jacqueline E Noll, Alanah L Bradey, et al.
The Pharmacogenomics Journal|February 8, 2012
Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsisM Man, S L Close, A D Shaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinomaR I Haddad, E Massarelli, J J Lee, et al.
Pageof 15